Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Midori Shimada

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Molecular Cell|June 10, 2014
Necessary and sufficient role for a mitosis skip in senescence inductionYoshikazu Johmura, Midori Shimada, Toshinori Misaki, et al.
Plos One|May 31, 2017
The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapyTsutomu Iwata, Tairin Uchino, Ayako Koyama, et al.
Thoracic Cancer|January 8, 2020
Vildagliptin-induced ground-glass nodules mimicking lung metastases in a cancer patient receiving Lactobacillus probiotic supplementationYasuhiro Tanaka, Hiroshi Soda, Yuichi Fukuda, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2022
FKBP52 and FKBP51 differentially regulate the stability of estrogen receptor in breast cancerMakoto Habara, Yuki Sato, Takahiro Goshima, et al.
Thoracic Cancer|August 4, 2017
Phase I study of pemetrexed and concurrent radiotherapy for previously untreated elderly patients with locally advanced non-squamous non-small cell lung cancerShinnosuke Takemoto, Yoichi Nakamura, Minoru Fukuda, et al.
Nature Communications|March 1, 2019
Cdk1-mediated DIAPH1 phosphorylation maintains metaphase cortical tension and inactivates the spindle assembly checkpoint at anaphaseKoutarou Nishimura, Yoshikazu Johmura, Katashi Deguchi, et al.
Thoracic Cancer|July 8, 2016
Prospective study of the UGT1A1*27 gene polymorphism during irinotecan therapy in patients with lung cancer: Results of Lung Oncology Group in Kyusyu (LOGIK1004B)Minoru Fukuda, Takayuki Suetsugu, Midori Shimada, et al.
Thoracic Cancer|August 17, 2022
Immunosuppressive tumor microenvironment in extraskeletal myxoid chondrosarcoma: A case of pleural metastasesRyosuke Ogata, Hiroshi Soda, Hiroaki Senju, et al.
Thoracic Cancer|November 25, 2016
Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1*28 or *6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A)Minoru Fukuda, Midori Shimada, Takeshi Kitazaki, et al.
Thoracic Cancer|May 29, 2020
Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II studyTakaya Ikeda, Shinnosuke Takemoto, Hiroaki Senju, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Molecular Cell|June 10, 2014
Necessary and sufficient role for a mitosis skip in senescence inductionYoshikazu Johmura, Midori Shimada, Toshinori Misaki, et al.
Plos One|May 31, 2017
The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapyTsutomu Iwata, Tairin Uchino, Ayako Koyama, et al.
Thoracic Cancer|January 8, 2020
Vildagliptin-induced ground-glass nodules mimicking lung metastases in a cancer patient receiving Lactobacillus probiotic supplementationYasuhiro Tanaka, Hiroshi Soda, Yuichi Fukuda, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2022
FKBP52 and FKBP51 differentially regulate the stability of estrogen receptor in breast cancerMakoto Habara, Yuki Sato, Takahiro Goshima, et al.
Thoracic Cancer|August 4, 2017
Phase I study of pemetrexed and concurrent radiotherapy for previously untreated elderly patients with locally advanced non-squamous non-small cell lung cancerShinnosuke Takemoto, Yoichi Nakamura, Minoru Fukuda, et al.
Nature Communications|March 1, 2019
Cdk1-mediated DIAPH1 phosphorylation maintains metaphase cortical tension and inactivates the spindle assembly checkpoint at anaphaseKoutarou Nishimura, Yoshikazu Johmura, Katashi Deguchi, et al.
Thoracic Cancer|July 8, 2016
Prospective study of the UGT1A1*27 gene polymorphism during irinotecan therapy in patients with lung cancer: Results of Lung Oncology Group in Kyusyu (LOGIK1004B)Minoru Fukuda, Takayuki Suetsugu, Midori Shimada, et al.
Thoracic Cancer|August 17, 2022
Immunosuppressive tumor microenvironment in extraskeletal myxoid chondrosarcoma: A case of pleural metastasesRyosuke Ogata, Hiroshi Soda, Hiroaki Senju, et al.
Thoracic Cancer|November 25, 2016
Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1*28 or *6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A)Minoru Fukuda, Midori Shimada, Takeshi Kitazaki, et al.
Thoracic Cancer|May 29, 2020
Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II studyTakaya Ikeda, Shinnosuke Takemoto, Hiroaki Senju, et al.
Pageof 8